FDA warning letters target two firms in India for GMP violations, US sponsor for BIMO violations
Regulatory NewsJoanne S. Eglovitch
APIsChemistry, Manufacturing and Controls (CMC)ComplianceGMPManufacturingPharmaceuticalsQuality Assurance and ControlRecallsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Warning letters